In a nitroglycerin‐induced acute migraine mouse model, the selective TRPA1 antagonist ADM_12 significantly attenuates microglial and astrocytic activation within the trigeminal nucleus caudalis (TNC), and reduces satellite glial cell activation in the TG, consequently reversing hyperalgesia [46]. This evidence concerns the gene TRPA1 and migraine disorder.